0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Canine Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: November 2022
|
Report Code: QYRE-Auto-25Y6061
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Canine Stem Cell Therapy Market Insights and Forecast to 2028
BUY CHAPTERS

Global Canine Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-25Y6061
Report
November 2022
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Canine Stem Cell Therapy estimated at US$ 106 million in the year 2022, is projected to reach a revised size of US$ 122.3 million by 2028, growing at a CAGR of 2.4% during the forecast period 2022-2028.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Canine Stem Cell Therapy companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Canine Stem Cell Therapy market. Further, it explains the major drivers and regional dynamics of the global Canine Stem Cell Therapy market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Canine Stem Cell Therapy Segment by Type

Allogeneic Stem Cells
Autologous Stem cells

Canine Stem Cell Therapy Segment by Application

Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Canine Stem Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Canine Stem Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Canine Stem Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Canine Stem Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Canine Stem Cell Therapy revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Canine Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Canine Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix and Magellan Stem Cells, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Stem Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Allogeneic Stem Cells
1.2.3 Autologous Stem cells
1.3 Market by Application
1.3.1 Global Canine Stem Cell Therapy Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Canine Stem Cell Therapy Market Size (2017-2028)
2.2 Canine Stem Cell Therapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Canine Stem Cell Therapy Market Size by Region (2017-2022)
2.4 Global Canine Stem Cell Therapy Market Size Forecast by Region (2023-2028)
2.5 Global Top Canine Stem Cell Therapy Countries Ranking by Market Size
3 Canine Stem Cell Therapy Competitive by Company
3.1 Global Canine Stem Cell Therapy Revenue by Players
3.1.1 Global Canine Stem Cell Therapy Revenue by Players (2017-2022)
3.1.2 Global Canine Stem Cell Therapy Market Share by Players (2017-2022)
3.2 Global Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Canine Stem Cell Therapy Revenue
3.4 Global Canine Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Canine Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Stem Cell Therapy Revenue in 2021
3.5 Global Canine Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Canine Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Canine Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Canine Stem Cell Therapy Breakdown Data by Type
4.1 Global Canine Stem Cell Therapy Historic Revenue by Type (2017-2022)
4.2 Global Canine Stem Cell Therapy Forecasted Revenue by Type (2023-2028)
5 Global Canine Stem Cell Therapy Breakdown Data by Application
5.1 Global Canine Stem Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Canine Stem Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Canine Stem Cell Therapy Revenue by Company (2020-2022)
6.2 North America Canine Stem Cell Therapy Revenue by Type (2017-2028)
6.3 North America Canine Stem Cell Therapy Revenue by Application (2017-2028)
6.4 North America Canine Stem Cell Therapy Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Canine Stem Cell Therapy Revenue by Company (2020-2022)
7.2 Europe Canine Stem Cell Therapy Revenue by Type (2017-2028)
7.3 Europe Canine Stem Cell Therapy Revenue by Application (2017-2028)
7.4 Europe Canine Stem Cell Therapy Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Canine Stem Cell Therapy Revenue by Company (2020-2022)
8.2 Asia Pacific Canine Stem Cell Therapy Revenue by Type (2017-2028)
8.3 Asia Pacific Canine Stem Cell Therapy Revenue by Application (2017-2028)
8.4 Asia Pacific Canine Stem Cell Therapy Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Canine Stem Cell Therapy Revenue by Company (2020-2022)
9.2 Latin America Canine Stem Cell Therapy Revenue by Type (2017-2028)
9.3 Latin America Canine Stem Cell Therapy Revenue by Application (2017-2028)
9.4 Latin America Canine Stem Cell Therapy Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Canine Stem Cell Therapy Revenue by Company (2020-2022)
10.2 Middle East and Africa Canine Stem Cell Therapy Revenue by Type (2017-2028)
10.3 Middle East and Africa Canine Stem Cell Therapy Revenue by Application (2017-2028)
10.4 Middle East and Africa Canine Stem Cell Therapy Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 VETSTEM BIOPHARMA
11.1.1 VETSTEM BIOPHARMA Company Details
11.1.2 VETSTEM BIOPHARMA Business Overview
11.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Products and Services
11.1.4 VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.1.5 VETSTEM BIOPHARMA Canine Stem Cell Therapy SWOT Analysis
11.1.6 VETSTEM BIOPHARMA Recent Developments
11.2 Cell Therapy Sciences
11.2.1 Cell Therapy Sciences Company Details
11.2.2 Cell Therapy Sciences Business Overview
11.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Products and Services
11.2.4 Cell Therapy Sciences Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.2.5 Cell Therapy Sciences Canine Stem Cell Therapy SWOT Analysis
11.2.6 Cell Therapy Sciences Recent Developments
11.3 Regeneus
11.3.1 Regeneus Company Details
11.3.2 Regeneus Business Overview
11.3.3 Regeneus Canine Stem Cell Therapy Products and Services
11.3.4 Regeneus Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.3.5 Regeneus Canine Stem Cell Therapy SWOT Analysis
11.3.6 Regeneus Recent Developments
11.4 Aratana Therapeutics
11.4.1 Aratana Therapeutics Company Details
11.4.2 Aratana Therapeutics Business Overview
11.4.3 Aratana Therapeutics Canine Stem Cell Therapy Products and Services
11.4.4 Aratana Therapeutics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.4.5 Aratana Therapeutics Canine Stem Cell Therapy SWOT Analysis
11.4.6 Aratana Therapeutics Recent Developments
11.5 Medivet Biologics
11.5.1 Medivet Biologics Company Details
11.5.2 Medivet Biologics Business Overview
11.5.3 Medivet Biologics Canine Stem Cell Therapy Products and Services
11.5.4 Medivet Biologics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.5.5 Medivet Biologics Canine Stem Cell Therapy SWOT Analysis
11.5.6 Medivet Biologics Recent Developments
11.6 Okyanos
11.6.1 Okyanos Company Details
11.6.2 Okyanos Business Overview
11.6.3 Okyanos Canine Stem Cell Therapy Products and Services
11.6.4 Okyanos Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.6.5 Okyanos Canine Stem Cell Therapy SWOT Analysis
11.6.6 Okyanos Recent Developments
11.7 Vetbiologics
11.7.1 Vetbiologics Company Details
11.7.2 Vetbiologics Business Overview
11.7.3 Vetbiologics Canine Stem Cell Therapy Products and Services
11.7.4 Vetbiologics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.7.5 Vetbiologics Canine Stem Cell Therapy SWOT Analysis
11.7.6 Vetbiologics Recent Developments
11.8 VetMatrix
11.8.1 VetMatrix Company Details
11.8.2 VetMatrix Business Overview
11.8.3 VetMatrix Canine Stem Cell Therapy Products and Services
11.8.4 VetMatrix Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.8.5 VetMatrix Canine Stem Cell Therapy SWOT Analysis
11.8.6 VetMatrix Recent Developments
11.9 Magellan Stem Cells
11.9.1 Magellan Stem Cells Company Details
11.9.2 Magellan Stem Cells Business Overview
11.9.3 Magellan Stem Cells Canine Stem Cell Therapy Products and Services
11.9.4 Magellan Stem Cells Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.9.5 Magellan Stem Cells Canine Stem Cell Therapy SWOT Analysis
11.9.6 Magellan Stem Cells Recent Developments
11.10 ANIMAL CELL THERAPIES
11.10.1 ANIMAL CELL THERAPIES Company Details
11.10.2 ANIMAL CELL THERAPIES Business Overview
11.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Products and Services
11.10.4 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.10.5 ANIMAL CELL THERAPIES Canine Stem Cell Therapy SWOT Analysis
11.10.6 ANIMAL CELL THERAPIES Recent Developments
11.11 Stemcellvet
11.11.1 Stemcellvet Company Details
11.11.2 Stemcellvet Business Overview
11.11.3 Stemcellvet Canine Stem Cell Therapy Products and Services
11.11.4 Stemcellvet Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)
11.11.5 Stemcellvet Recent Developments
12 Canine Stem Cell Therapy Market Dynamics
12.1 Canine Stem Cell Therapy Market Trends
12.2 Canine Stem Cell Therapy Market Drivers
12.3 Canine Stem Cell Therapy Market Challenges
12.4 Canine Stem Cell Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
    Table 1. Global Canine Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Allogeneic Stem Cells
    Table 3. Key Players of Autologous Stem cells
    Table 4. Global Canine Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Canine Stem Cell Therapy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 6. Global Canine Stem Cell Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 7. Global Canine Stem Cell Therapy Revenue Market Share by Region (2017-2022)
    Table 8. Global Canine Stem Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 9. Global Canine Stem Cell Therapy Market Share by Players (2017-2022)
    Table 10. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Stem Cell Therapy as of 2021)
    Table 11. Ranking of Global Top Canine Stem Cell Therapy Companies by Revenue (US$ Million) in 2021
    Table 12. Global 5 Largest Players Market Share by Canine Stem Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 13. Key Players Headquarters and Area Served
    Table 14. Key Players Canine Stem Cell Therapy Product Solution and Service
    Table 15. Date of Key Manufacturers Enter into Canine Stem Cell Therapy Market
    Table 16. Mergers & Acquisitions, Expansion Plans
    Table 17. Global Canine Stem Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 18. Global Canine Stem Cell Therapy Revenue Market Share by Type (2017-2022)
    Table 19. Global Canine Stem Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 20. Global Canine Stem Cell Therapy Revenue Market Share by Type (2023-2028)
    Table 21. Global Canine Stem Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 22. Global Canine Stem Cell Therapy Revenue Market Share by Application (2017-2022)
    Table 23. Global Canine Stem Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 24. Global Canine Stem Cell Therapy Revenue Market Share by Application (2023-2028)
    Table 25. North America Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 26. North America Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 27. North America Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 28. North America Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 29. North America Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 30. North America Canine Stem Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 31. North America Canine Stem Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 32. Europe Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 33. Europe Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Europe Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Europe Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 36. Europe Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 37. Europe Canine Stem Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Europe Canine Stem Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 39. Asia Pacific Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 40. Asia Pacific Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 41. Asia Pacific Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 42. Asia Pacific Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Asia Pacific Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Canine Stem Cell Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Canine Stem Cell Therapy Revenue by Region (2023-2028) & (US$ Million)
    Table 46. Latin America Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 47. Latin America Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 48. Latin America Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 49. Latin America Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 50. Latin America Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 51. Latin America Canine Stem Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 52. Latin America Canine Stem Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 53. Middle East and Africa Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)
    Table 54. Middle East and Africa Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 55. Middle East and Africa Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Canine Stem Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Canine Stem Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 60. VETSTEM BIOPHARMA Company Details
    Table 61. VETSTEM BIOPHARMA Business Overview
    Table 62. VETSTEM BIOPHARMA Canine Stem Cell Therapy Product and Services
    Table 63. VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 64. VETSTEM BIOPHARMA Canine Stem Cell Therapy SWOT Analysis
    Table 65. VETSTEM BIOPHARMA Recent Developments
    Table 66. Cell Therapy Sciences Company Details
    Table 67. Cell Therapy Sciences Business Overview
    Table 68. Cell Therapy Sciences Canine Stem Cell Therapy Product and Services
    Table 69. Cell Therapy Sciences Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 70. Cell Therapy Sciences Canine Stem Cell Therapy SWOT Analysis
    Table 71. Cell Therapy Sciences Recent Developments
    Table 72. Regeneus Company Details
    Table 73. Regeneus Business Overview
    Table 74. Regeneus Canine Stem Cell Therapy Product and Services
    Table 75. Regeneus Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 76. Regeneus Canine Stem Cell Therapy SWOT Analysis
    Table 77. Regeneus Recent Developments
    Table 78. Aratana Therapeutics Company Details
    Table 79. Aratana Therapeutics Business Overview
    Table 80. Aratana Therapeutics Canine Stem Cell Therapy Product and Services
    Table 81. Aratana Therapeutics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 82. Aratana Therapeutics Canine Stem Cell Therapy SWOT Analysis
    Table 83. Aratana Therapeutics Recent Developments
    Table 84. Medivet Biologics Company Details
    Table 85. Medivet Biologics Business Overview
    Table 86. Medivet Biologics Canine Stem Cell Therapy Product and Services
    Table 87. Medivet Biologics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 88. Medivet Biologics Canine Stem Cell Therapy SWOT Analysis
    Table 89. Medivet Biologics Recent Developments
    Table 90. Okyanos Company Details
    Table 91. Okyanos Business Overview
    Table 92. Okyanos Canine Stem Cell Therapy Product and Services
    Table 93. Okyanos Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 94. Okyanos Canine Stem Cell Therapy SWOT Analysis
    Table 95. Okyanos Recent Developments
    Table 96. Vetbiologics Company Details
    Table 97. Vetbiologics Business Overview
    Table 98. Vetbiologics Canine Stem Cell Therapy Product and Services
    Table 99. Vetbiologics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 100. Vetbiologics Canine Stem Cell Therapy SWOT Analysis
    Table 101. Vetbiologics Recent Developments
    Table 102. VetMatrix Company Details
    Table 103. VetMatrix Business Overview
    Table 104. VetMatrix Canine Stem Cell Therapy Product and Services
    Table 105. VetMatrix Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 106. VetMatrix Canine Stem Cell Therapy SWOT Analysis
    Table 107. VetMatrix Recent Developments
    Table 108. Magellan Stem Cells Company Details
    Table 109. Magellan Stem Cells Business Overview
    Table 110. Magellan Stem Cells Canine Stem Cell Therapy Product and Services
    Table 111. Magellan Stem Cells Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 112. Magellan Stem Cells Canine Stem Cell Therapy SWOT Analysis
    Table 113. Magellan Stem Cells Recent Developments
    Table 114. ANIMAL CELL THERAPIES Company Details
    Table 115. ANIMAL CELL THERAPIES Business Overview
    Table 116. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product and Services
    Table 117. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 118. ANIMAL CELL THERAPIES Canine Stem Cell Therapy SWOT Analysis
    Table 119. ANIMAL CELL THERAPIES Recent Developments
    Table 120. Stemcellvet Company Details
    Table 121. Stemcellvet Business Overview
    Table 122. Stemcellvet Canine Stem Cell Therapy Product and Services
    Table 123. Stemcellvet Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)
    Table 124. Stemcellvet Recent Developments
    Table 125. Canine Stem Cell Therapy Market Trends
    Table 126. Canine Stem Cell Therapy Market Drivers
    Table 127. Canine Stem Cell Therapy Market Challenges
    Table 128. Canine Stem Cell Therapy Market Restraints
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Canine Stem Cell Therapy Sales Market Share by Type: 2021 VS 2028
    Figure 2. Allogeneic Stem Cells Features
    Figure 3. Autologous Stem cells Features
    Figure 4. Global Canine Stem Cell Therapy Sales Market Share by Application: 2021 VS 2028
    Figure 5. Veterinary Hospitals Case Studies
    Figure 6. Veterinary Clinics Case Studies
    Figure 7. Veterinary Research Institutes Case Studies
    Figure 8. Canine Stem Cell Therapy Report Years Considered
    Figure 9. Global Canine Stem Cell Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Canine Stem Cell Therapy Market Size 2017-2028 (US$ Million)
    Figure 11. Global Canine Stem Cell Therapy Market Size Market Share by Region: 2021 VS 2028
    Figure 12. Global Canine Stem Cell Therapy Revenue Market Share by Region in 2017 VS 2022
    Figure 13. Global Top 10 Canine Stem Cell Therapy Countries Ranking by Market Size (US$ Million) in 2021
    Figure 14. Global Canine Stem Cell Therapy Market Share by Players in 2021
    Figure 15. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Stem Cell Therapy as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Canine Stem Cell Therapy Revenue in 2021
    Figure 17. North America Canine Stem Cell Therapy Revenue Market Share by Company in 2021
    Figure 18. North America Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)
    Figure 19. North America Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)
    Figure 20. North America Canine Stem Cell Therapy Revenue Share by Country (2017-2028)
    Figure 21. U.S. Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 22. Canada Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 23. Europe Canine Stem Cell Therapy Revenue Market Share by Company in 2021
    Figure 24. Europe Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)
    Figure 25. Europe Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)
    Figure 26. Europe Canine Stem Cell Therapy Revenue Share by Country (2017-2028)
    Figure 27. Germany Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 28. France Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 29. U.K. Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 30. Italy Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 31. Russia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Canine Stem Cell Therapy Revenue Market Share by Company in 2021
    Figure 33. Asia Pacific Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Canine Stem Cell Therapy Revenue Share by Region (2017-2028)
    Figure 36. China Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 37. Japan Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 38. South Korea Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 39. India Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 40. Australia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 41. Taiwan Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 42. Indonesia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 43. Thailand Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 44. Malaysia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 45. Philippines Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 46. Vietnam Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 47. Latin America Canine Stem Cell Therapy Revenue Market Share by Company in 2021
    Figure 48. Latin America Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)
    Figure 49. Latin America Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)
    Figure 50. Latin America Canine Stem Cell Therapy Revenue Share by Country (2017-2028)
    Figure 51. Mexico Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 52. Brazil Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 53. Argentina Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Canine Stem Cell Therapy Revenue Market Share by Company in 2021
    Figure 55. Middle East and Africa Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)
    Figure 56. Middle East and Africa Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)
    Figure 57. Middle East and Africa Canine Stem Cell Therapy Revenue Share by Country (2017-2028)
    Figure 58. Turkey Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 59. Saudi Arabia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 60. U.A.E Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)
    Figure 61. VETSTEM BIOPHARMA Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 62. Cell Therapy Sciences Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 63. Regeneus Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 64. Aratana Therapeutics Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 65. Medivet Biologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 66. Okyanos Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 67. Vetbiologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 68. VetMatrix Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 69. Magellan Stem Cells Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 70. ANIMAL CELL THERAPIES Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 71. Stemcellvet Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture